Recently, PD-1 and LAG-3 signaling were shown to limit T cell anti-tumour immune responses, and knockout of both genes induced NKG2A expression on tumour-specific T cells, illustrating the interplay between checkpoint receptor expression and highlighting the selective expression of NKG2A on tumour-specific T cells [100]. This evidence concerns the gene KLRC1 and neoplasm.